About GenXys
GenXys is a Healthcare company based in Vancouver (Canada) founded in 2014 by Martin Dawes. It operates as a provider of pharmacogenetic testing and a medication decision support system. GenXys has raised $1.33 million across 2 funding rounds from investors including GreenShield, TYDO INCUBATOR and TELUS Ventures. Its chief executive is Martin Dawes. GenXys offers products and services including LabGx, CDSS, and OptimizeGx. Its focus areas include Life Sciences, Genomics, Applied Genomics and Consumer Genomics. Its competitors include Invitae, Newtopia, VitaminLab, Inagene and GeneYouIn and 4 more; 3 of its 9 listed competitors have raised funding.
Company details
GenXys was founded in 2014 in Vancouver, Canada, within the healthcare sector focused on pharmacogenetics. Services include TreatGxPlus, a home collection kit ordered by consumers for genetic variant analysis affecting medication responses, with reports shared for professional consultations. TreatGx, a decision support tool, is offered to healthcare providers, integrating pharmacogenetic data, medical history, and clinical evidence to suggest tailored medication options. Operations emphasize evidence-based personalization across North America.
- Headquarters Vancouver, Canada
- Founders Martin Dawes
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website genxys.com
- Social LinkedIn X Facebook
- Total Equity Funding$1.33M (USD)
in 2 rounds
- InvestorsGreenShield
& 2 more
Products & Services of GenXys
GenXys offers a comprehensive portfolio of products and services, including LabGx, CDSS, and OptimizeGx.
Integrates genomic data for clinical decision-making in prescribing.
Delivers personalized treatment recommendations based on patient profiles.
Streamlines authorization processes for specialty medications.
Funding Insights of GenXys
GenXys has successfully raised a total of $1.33M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.33M
- Total Rounds 2
- First Round $1.33M
(Apr 2019)
- Investors Count 3
All 2 funding rounds of GenXys with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2020 | – | Seed | – | GSC | – |
| Apr 2019 | $1.33M | Seed | – | TYDO INCUBATOR, TELUS Ventures | – |
3 investors in total: 3 institutional.
Investors in GenXys
GenXys has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include GreenShield, TYDO INCUBATOR and TELUS Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | tydo.ca | - | |
Investments in multiple sectors are directed by TELUS Ventures. | – | telus.com/ventures | Vancouver, Canada | |
GreenShield is recognized for providing integrated health coverage and care. | 1957 | greenshield.ca | Windsor, Canada |
Investor details for GenXys
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of GenXys
9 people are tracked at GenXys (2 in leadership, 6 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Martin Dawes | Founder & CEO | Leadership |
Gustavo Bernard Esquivel Zavala | Chief Medical Officer | Leadership |
Karen Boodram | Advisor | Board & advisors |
Diana Dawes | Advisor | Board & advisors |
Jillian Reardon | Advisor | Board & advisors |
Penny Miller | Advisor | Board & advisors |
Ohad Arazi | Independent Board Member | Board & advisors |
Mark Gelfer | Chairman | Board & advisors |
Amy Andersen | SVP Growth | Team |
Complete people profiles for GenXys
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of GenXys
3 dated milestones of GenXys across 6 years, from founding to its latest funding, stage changes and deals.
- Founded GenXys is founded.
- Funding First funding round of $1.3M.
- Funding Latest funding round, Seed,.
Competitors of GenXys
GenXys has 9 listed competitors in our database, 3 of them funded. They include Invitae, Newtopia, VitaminLab, Inagene and GeneYouIn, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| invitae.com | 2010 | San Francisco, United States | $189.56M | 1,700 | Home-based genetic tests for detecting diseases are provided to individuals. | |
| newtopia.com | 2008 | New York, United States | $13.1M | – | Health management platform is provided for employers and insurers. | |
| getvitaminlab.com | 2016 | Victoria, Canada | – | 49 | Personalized supplements are developed using blood and genetic tests. | |
| inagene.com | 2018 | Toronto, Canada | – | – | Provider of genetic test for pain management | |
| geneyouin.ca | 2012 | Toronto, Canada | – | – | Provider of solutions to patients and their healthcare practitioners by providing insight into how they respond to specific medications based on their genetic profile | |
| arcticdx.com | 2005 | Toronto, Canada | – | – | Molecular diagnostic tests for multiple diseases are developed. | |
| geneblueprint.com | 2016 | Hamilton, Canada | – | – | Provider of platform for personal fitness and nutrition based on DNA tests | |
| biopeak.com | 2002 | Bengaluru, India | $4.93M | – | Provider of a range of health and wellness products | |
| thednacompany.com | 2018 | Mississauga, Canada | – | – | Provides DNA testing, health reports, coaching, and supplements for personalized wellness. |
Detailed competitors of GenXys
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of GenXys
The website of GenXys (genxys.com) receives about 6.3K visits a month.
- Monthly visits6.3K
▼ 7% vs previous month
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as GenXys (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genxys
Complete news archive for GenXys
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GenXys
GenXys was founded in 2014 and raised its 1st funding round 5 years after it was founded.
GenXys is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Martin Dawes is the current CEO of GenXys. They have also founded this company.
GenXys is a funded company, having raised a total of $1.33M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.33M, raised on Apr 2019.
GenXys was founded in 2014 in Vancouver, Canada, within the healthcare sector focused on pharmacogenetics. Services include TreatGxPlus, a home collection kit ordered by consumers for genetic variant analysis affecting medication responses, with reports shared for professional consultations. TreatGx, a decision support tool, is offered to healthcare providers, integrating pharmacogenetic data, medical history, and clinical evidence to suggest tailored medication options. Operations emphasize evidence-based personalization across North America.
GenXys's top competitors include Newtopia, Invitae and VitaminLab.
GenXys offers LabGx, CDSS, and OptimizeGx.
GenXys has 3 investors. Key investors include GreenShield, TYDO INCUBATOR, and TELUS Ventures.